327 related articles for article (PubMed ID: 35373286)
21. Advanced Percutaneous Mechanical Circulatory Support Devices for Cardiogenic Shock.
Miller PE; Solomon MA; McAreavey D
Crit Care Med; 2017 Nov; 45(11):1922-1929. PubMed ID: 28857849
[TBL] [Abstract][Full Text] [Related]
22. Outcome of Temporary Circulatory Support As a Bridge-to-Left Ventricular Assist Device Strategy in Cardiogenic Shock Patients.
Bidaut A; Flécher E; Nesseler N; Bounader K; Vincentelli A; Moussa M; Delmas C; Porterie J; Nubret K; Pernot M; Kindo M; Schneider C; Gaudard P; Rouvière P; Michel M; Sénage T; Boignard A; Chavanon O; Verdonk C; Para M; Maille B; Gariboldi V; Pozzi M; Hugon-Vallet E; Litzler PY; Anselme F; Blanchart K; Babatasi G; Bielefeld M; Grosjean S; Radu C; Hamon D; Bourguignon T; Genet T; Eschalier R; D'Ostrevy N; Nougue H; Martin AC; Vanhuyse F; Blangy H; Leclercq C; Martins RP; Galand V
Crit Care Med; 2022 May; 50(5):e426-e433. PubMed ID: 34974497
[TBL] [Abstract][Full Text] [Related]
23. Percutaneous left-ventricular support with the Impella-2.5-assist device in acute cardiogenic shock: results of the Impella-EUROSHOCK-registry.
Lauten A; Engström AE; Jung C; Empen K; Erne P; Cook S; Windecker S; Bergmann MW; Klingenberg R; Lüscher TF; Haude M; Rulands D; Butter C; Ullman B; Hellgren L; Modena MG; Pedrazzini G; Henriques JP; Figulla HR; Ferrari M
Circ Heart Fail; 2013 Jan; 6(1):23-30. PubMed ID: 23212552
[TBL] [Abstract][Full Text] [Related]
24. Advantages of intraoperative implantation of Impella 5.5 SmartAssist in the Management of Acute Post-Infarction Ventricular Septal Defect with cardiogenic shock.
Madjarov JM; Katz MG; Madzharov S; Fazal S; Robicsek F
J Cardiothorac Surg; 2021 May; 16(1):132. PubMed ID: 34001192
[TBL] [Abstract][Full Text] [Related]
25. Posterior ventricular septal defect in presence of cardiogenic shock: early implantation of the impella recover LP 5.0 as a bridge to surgery.
La Torre MW; Centofanti P; Attisani M; Patanè F; Rinaldi M
Tex Heart Inst J; 2011; 38(1):42-9. PubMed ID: 21423467
[TBL] [Abstract][Full Text] [Related]
26. Aortic thrombosis with visceral malperfusion during circulatory support with a combination of Impella and extracorporeal membrane oxygenation for postcardiotomy cardiogenic shock.
Yamana F; Domae K; Kawasumi R; Sakamoto T; Hata M; Shirakawa Y; Masai T; Sawa Y
J Artif Organs; 2023 Dec; 26(4):330-334. PubMed ID: 36705891
[TBL] [Abstract][Full Text] [Related]
27. Clinical outcomes of hundred large Impella implantations in cardiogenic shock patients based on individual clinical scenarios.
Sugimura Y; Bauer S; Immohr MB; Mehdiani A; Rellecke P; Tudorache I; Horn P; Westenfeld R; Boeken U; Aubin H; Lichtenberg A; Akhyari P
Artif Organs; 2023 Dec; 47(12):1874-1884. PubMed ID: 37724611
[TBL] [Abstract][Full Text] [Related]
28. Benefit of veno-arterial extracorporeal membrane oxygenation combined with Impella (ECpella) therapy in acute coronary syndrome with cardiogenic shock.
Shibasaki I; Masawa T; Abe S; Ogawa H; Takei Y; Tezuka M; Seki M; Kato T; Watanabe R; Koshiji N; Saitou S; Ogata K; Haruyama Y; Toyoda S; Fukuda H
J Cardiol; 2022 Aug; 80(2):116-124. PubMed ID: 35288000
[TBL] [Abstract][Full Text] [Related]
29. Impact of Impella Support on Clinical Outcomes in Patients with Postcardiotomy Cardiogenic Shock.
Sugimura Y; Immohr MB; Mehdiani A; Boeken U; Aubin H; Lichtenberg A; Akhyari P
Ann Thorac Cardiovasc Surg; 2024 Jan; 30(1):. PubMed ID: 37532525
[TBL] [Abstract][Full Text] [Related]
30. Impella and venoarterial extracorporeal membrane oxygenation in cardiogenic shock complicating acute myocardial infarction.
Bogerd M; Ten Berg S; Peters EJ; Vlaar APJ; Engström AE; Otterspoor LC; Jung C; Westermann D; Pöss J; Thiele H; Schrage B; Henriques JPS
Eur J Heart Fail; 2023 Nov; 25(11):2021-2031. PubMed ID: 37671582
[TBL] [Abstract][Full Text] [Related]
31. The role of the axillary Impella 5.0 device on patients with acute cardiogenic shock.
Tarabichi S; Ikegami H; Russo MJ; Lee LY; Lemaire A
J Cardiothorac Surg; 2020 Aug; 15(1):218. PubMed ID: 32795321
[TBL] [Abstract][Full Text] [Related]
32. Short-term mechanical circulatory support as a bridge to durable left ventricular assist device implantation in refractory cardiogenic shock: a systematic review and meta-analysis.
den Uil CA; Akin S; Jewbali LS; Dos Reis Miranda D; Brugts JJ; Constantinescu AA; Kappetein AP; Caliskan K
Eur J Cardiothorac Surg; 2017 Jul; 52(1):14-25. PubMed ID: 28472406
[TBL] [Abstract][Full Text] [Related]
33. Impella CP use in patients with non-ischaemic cardiogenic shock.
Maniuc O; Salinger T; Anders F; Müntze J; Liu D; Hu K; Ertl G; Frantz S; Nordbeck P
ESC Heart Fail; 2019 Aug; 6(4):863-866. PubMed ID: 31095902
[TBL] [Abstract][Full Text] [Related]
34. Short-Term Outcomes of Impella Support in Japanese Patients With Cardiogenic Shock Due to Acute Myocardial Infarction - Japanese Registry for Percutaneous Ventricular Assist Device (J-PVAD).
Ikeda Y; Ako J; Toda K; Hirayama A; Kinugawa K; Kobayashi Y; Ono M; Nishimura T; Sato N; Shindo T; Takayama M; Yasukochi S; Shiose A; Sawa Y;
Circ J; 2023 Apr; 87(5):588-597. PubMed ID: 36682787
[TBL] [Abstract][Full Text] [Related]
35. Outcomes of Impella 5.0 in Cardiogenic Shock: A Systematic Review and Meta-analysis.
Batsides G; Massaro J; Cheung A; Soltesz E; Ramzy D; Anderson MB
Innovations (Phila); 2018; 13(4):254-260. PubMed ID: 30142110
[TBL] [Abstract][Full Text] [Related]
36. Temporary mechanical circulatory support with Impella in cardiac surgery: A systematic review.
Pieri M; D'Andria Ursoleo J; Nardelli P; Ortalda A; Ajello S; Delrio S; Fominskiy E; Scandroglio AM
Int J Cardiol; 2024 Feb; 396():131418. PubMed ID: 37813286
[TBL] [Abstract][Full Text] [Related]
37. Reconsidering FDA Guidelines: A Single-Center Experience of Prolonged Impella 5.5 Support.
Valdes CA; Stinson G; Sharaf OM; Jimenez Contreras F; Bilgili A; Ahmed MM; Vilaro J; Parker AM; Al-Ani MAZ; Demos D; Aranda J; Bleiweis M; Beaver TM; Jeng EI
Innovations (Phila); 2024; 19(1):46-53. PubMed ID: 38013250
[TBL] [Abstract][Full Text] [Related]
38. Mechanical circulatory support with the Impella® LP5.0 pump and an intra-aortic balloon pump for cardiogenic shock in acute myocardial infarction: The IMPELLA-STIC randomized study.
Bochaton T; Huot L; Elbaz M; Delmas C; Aissaoui N; Farhat F; Mewton N; Bonnefoy E;
Arch Cardiovasc Dis; 2020 Apr; 113(4):237-243. PubMed ID: 31740272
[TBL] [Abstract][Full Text] [Related]
39. Overview of mechanical circulatory support for the management of post-myocardial infarction ventricular septal rupture.
Shibasaki I; Otani N; Saito S; Ogawa H; Masawa T; Tsuchiya G; Takei Y; Tezuka M; Kanazawa Y; Kanno Y; Yokoyama S; Hirota S; Niitsuma K; Matsuoka T; Konishi T; Ogata K; Ouchi M; Toyoda S; Fukuda H
J Cardiol; 2023 May; 81(5):491-497. PubMed ID: 36503063
[TBL] [Abstract][Full Text] [Related]
40. Management and outcome of patients supported with Impella 5.0 for refractory cardiogenic shock.
Gaudard P; Mourad M; Eliet J; Zeroual N; Culas G; Rouvière P; Albat B; Colson P
Crit Care; 2015 Oct; 19():363. PubMed ID: 26453047
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
